首页|肝素结合蛋白在血液灌流(HA380)联合连续性静脉-静脉血液滤过治疗脓毒症中变化及意义

肝素结合蛋白在血液灌流(HA380)联合连续性静脉-静脉血液滤过治疗脓毒症中变化及意义

扫码查看
目的 观察脓毒症患者行血液灌流(HP)(HA380)联合连续性静脉-静脉血液滤过(CVVH)治疗前、后血肝素结合蛋白(HBP)水平变化,探讨HBP在疗效评估中的意义.方法 2022年9月—2024年2月济宁市第一人民医院诊治脓毒症患者92例,随机分为观察组和对照组各46例.对照组给予常规治疗,观察组在常规治疗基础上行HP(HA380)联合CVVH的连续性血液净化治疗72 h.治疗前、治疗72 h后记录序贯器官衰竭评估(SOFA)评分、急性生理学和慢性健康状况评估Ⅱ(APACHE Ⅱ)评分、平均动脉压(MAP)、氧合指数(OI),测定动脉血HBP、降钙素原(PCT)、C反应蛋白(CRP)、乳酸、白细胞介素(IL)-6、IL-8、IL-10水平,计算SOFA评分降低率、HBP水平降低率.采用Spearman相关法分析观察组、对照组治疗前、后血HBP水平与SOFA评分的相关性及血HBP水平降低率与SOFA评分降低率的相关性.结果 治疗后观察组SOFA评分[(6.39±1.67)分]、APACHE Ⅱ评分[(11.48±1.81)分]及血HBP[176.38(154.99,192.27)μg/L]、PCT[32.07(28.84,36.40)μg/L]、CRP[125.36(112.87,144.48)mg/L]、乳酸[3.15(2.50,3.50)mmol/L]、IL-6[348.44(123.89,648.86)ng/L]、IL-8[133.47(77.47,248.04)ng/L]、IL-10[76.63(39.14,159.79)ng/L]水平均低于对照组[(9.11±2.11)分、(16.30±3.81)分、254.98(228.48,263.05)μg/L、61.74(48.62,65.67)μg/L、170.36(161.47,183.94)mg/L、3.80(3.30,4.53)mmol/L、456.00(252.35,1 666.37)ng/L、186.90(115.77,498.07)ng/L、141.76(62.04,783.80)ng/L](t=6.854、7.757,Z=-8.262、-7.583、-6.833、-5.487、-3.350、-2.608、-2.475;P 均<0.05),MAP[(84.25±2.25)mmHg]、OI[(265.19±12.85)mmHg]均高于对照组[(76.57±2.77)mmHg、(192.84±13.98)mmHg](t=-14.604,P<0.001;t=-25.844,P<0.001);2 组治疗后 SOFA评分、APACHE Ⅱ 评分及血 HBP、PCT、CRP、乳酸、IL-6、IL-8、IL-10 水平均低于治疗前(t=30.231~56.887,Z=-6.805~-4.905,P 均<0.05),MAP、OI 均高于治疗前(t=-122.463~-44.527,P 均<0.05);治疗前 2 组上述指标比较差异均无统计学意义(t=-1.748~0.387,Z=-1.914~-0.293,P均>0.05).治疗前、治疗后观察组(rs=0.714,P<0.001;rs=0.679,P<0.001)、对照组(rs=0.626,P<0.001;rs=0.697,P<0.001)血 HBP 水平与 SOFA 评分均呈正相关;观察组、对照组血HBP水平降低率与SOFA评分降低率均呈正相关(rs=0.446,P=0.002;rs=0.361,P=0.014).结论 脓毒症患者行HP(HA380)联合CVVH治疗可部分清除血液中HBP及炎症介质,减轻炎性反应,增加组织灌注,改善脏器功能;血HBP水平可评估脓毒症严重程度,其变化可反映HP(HA380)联合CVVH治疗的效果.
Change and significance of heparin-binding protein in hemoperfusion(HA380)combined with continuous veno-venous haemofiltration for sepsis
Objective To observe the changes of blood heparin-binding protein(HBP)after hemoperfusion(HA380)combined with continuous veno-venous haemodiafiltration(CVVH)in septic patients,and to explore the significance of HBP in assessing therapeutic effect.Methods Ninety-two septic patients were treated in Jining First People's Hospital from September 2022 to February 2024,and were randomly and equally divided into observation group and control group.Control group received conventional treatment,besides which observation group received continuous blood purification with hemoperfusion(HA380)combined with CVVH for 72 h.Sequential Organ Failure Assessment(SOFA)score,Acute Physiology and Chronic Health Evaluation Ⅱ(APACHE Ⅱ)score,mean arterial pressure,and oxygenation index were recorded before and 72 h after treatment.Arterial HBP,procalcitonin,C-reactive protein,lactate,interleukin(IL)-6,IL-8,and IL-10 levels were measured.The reduction rates of SOFA score and HBP level were calculated.Spearman's correlation method was used to analyze the correlation between HBP level and SOFA score,and between HBP level reduction rate and SOFA score reduction rate before and after treatment in two groups.Results The scores of SOFA and APACHE Ⅱ,and the levels of HBP,procalcitonin,C-reactive protein,lactate,IL-6,IL-8 and IL-10 were lower after treatment in observation group[6.39±1.67,11.48±1.81,176.38(154.99,192.27)μg/L,32.07(28.84,36.40)μg/L,125.36(112.87.144.48)mg/L,3.15(2.50,3.50)mmol/L,348.44(123.89,648.86)ng/L,133.47(77.47,248.04)ng/L,76.63(39.14,159.79)ng/L]than those in control group[9.11±2.11,16.30±3.81,254.98(228.48,263.05)μg/L,61.74(48.62,65.67)μg/L,170.36(161.47,183.94)mg/L,3.80(3.30,4.53)mmol/L,456.00(252.35,1 666.37)ng/L,186.90(115.77,498.07)ng/L,141.76(62.04,783.80)ng/L](t=6.854,t=7.757,Z=-8.262,Z=-7.583,Z=-6.833,Z=-5.487,Z=-3.350,Z=-2.608,Z=-2.475;all P values<0.05),and were lower in both groups after treatment than those before treatment(t=30.231-56.887,Z=-6.805 to-4.905;all P values<0.05).The mean arterial pressure and oxygenation index were higher after treatment in observation group[(84.25±2.25),(265.19±12.85)mmHg]than those in control group[(76.57±2.77),(192.84±13.98)mmHg](t--14.604,P<0.001;t=-25.844,P<0.001),and were higher in both groups after treatment than those before treatment(t=-122.463 to-44.527;all P values<0.05).All the above indexes showed no significant differences between two groups before treatment(t=-1.748-0.387,Z=-1.914 to-0.293;all P values>0.05).Both before and after treatment,the HBP levels were positively correlated with SOFA scores in observation group(rs=0.714,P<0.001;rs=0.679,P<0.001)and in control group(rs=0.626,P<0.001;r,=0.697,P<0.001);and the reduction rates of HBP levels were positively correlated with the reduction rates of SOFA scores in observation and control groups(rs=0.446,P=0.002;r,=0.361,P=0.014).Conclusions Hemoperfusion(HA380)combined with CVVH can partially remove HBP and inflammatory mediators from the blood of septic patients,reduce inflammatory response,increase tissue perfusion and improve organ function.The HBP level can be used to assess the severity of sepsis and its change may reflect the effect of hemoperfusion(HA380)combined with CVVH treatment.

sepsisheparin-binding proteinhemoperfusionHA380continuous veno-venous haemofiltration

刘威、孙小者、苏龙

展开 >

济宁医学院临床医学院,山东济宁 272013

济宁市第一人民医院重症医学科,山东济宁 272011

脓毒症 肝素结合蛋白 血液灌流 HA380 连续性静脉-静脉血液滤过

2024

中华实用诊断与治疗杂志
中华预防医学会 河南省人民医院

中华实用诊断与治疗杂志

CSTPCD
影响因子:1.276
ISSN:1674-3474
年,卷(期):2024.38(10)